Pulished Date August, 2019
ID: 1501
Share on
Share on

Global Antivenom Market Analysis - By Type (Vaccines, Hyperimmune Sera(Homologous and Heterologous)), By Animal (Snakes, Scorpions, Spiders and Others), By Region - Industry Size, Share, Trends, Growth and Forecast | 2019 - 2024

Pulished: August, 2019
ID: 1501
Pages: 175

Global Antivenom Market Size & Growth (2019 - 2024)

As per our report, the size for the Antivenom Market at a global level is expected to reach USD 1.9 billion by 2024 from USD 2.6 billion in 2019, growing at a CAGR of 6.18% during the forecast period 2019 - 2024.

Antivenom is a biological product that is used for the treatment of poisonous bites or stings of spiders, snakes, scorpions, and others. Snake bites are one of the major threats which can be fatal and every year so many people are dying around the world due to lack of treatment on time. Antivenoms should be used with proper knowledge while treating the snake bites, or else it may not be active or may lead to other side effects. There are two types of antivenom which are known as monovalent and polyvalent.

The rise in the incidence of snake bites and people getting aware of treatments due to modernization and globalization are leading to constant growth in demand of the antivenom market across the world. Government authorities in developing countries are taking measures to prevent loss of life due to snake bites and other venomous bites to enhance healthcare services which are fuelling the growth of the antivenom market. Also, medical research organizations are continually developing effective treatment methods and antivenom to tackle the seriousness of the venomous bites, which is catalyzing the business.

Uncertainties in standards of quality and improper application of antivenom are limiting the growth rate of the global antivenom market. High costs associated with manufacturing and lack of proper investments by public and private organizations and inefficient manufacturing procedures are restraining the growth of the global antivenom market. Other factors that are challenging the growth of the market are inappropriate regulations, shortage of skilled professionals in drug control laboratories, lack of specifications and proper knowledge regarding the types of toxic and lethal venom types which would affect the treatment procedure, belief systems in some countries like India and particularly in rural areas where the incidence of snake bites are more frequent, and lack of proper distribution networks of venom due to inadequate infrastructure of healthcare in developing countries.

Rising awareness among people and recognizing the snakebite as a medical emergency in rural areas is expected to boost the demand for treatments for snakebites, which will offer growth opportunities for the antivenom market during the forecast period. Rising focus on research and development activities from the private and public organizations for developing high-quality antivenoms owing to immense advancements in medical science and technology to meet the continuously rising demand of the antivenoms due to rise in mortality rate is expected to create more growth opportunities for the market over the forecast period. The market is supposed to offer a number of opportunities for the key players owing to the unmet demand of antivenoms in countries like Africa, Asia, and Latin America. An increasing number of novel product developments and launches and a more natural approval process are also foreseen to create lucrative growth opportunities for the global antivenom market during the forecast period.

Major Happenings in this market in the recent past:

  • In May 2019: snakebite crisis organization raised funds for developing high-quality and treatment enhancing antivenoms in order to meet the continually rising need of antivenoms.
  • In 2018: Pzifer Company extended the expiration date up to 12 months for their product called antivenin with the help of food and drug administration.
  • In 2018: the University of Arizona had developed an antivenom called polyvalent F(ab)2 Equine which can be used for treating bite caused by a snake in North America called Micrurus.
  • May 2017: Snakebite911, an app that contains educational information on snakes and snakes bite first-aid support, developed by BTG PLC.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Animal and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh) and Bharat Serum

 

This research report on the Global Antivenom Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast until 2024.

Antivenom Market Analysis - By Type

  • Vaccines
  • Hyperimmune Sera
    • Homologous
    • Heterologous

Antivenom Market Analysis - By Animal

  • Snakes
  • Scorpions
  • Spiders
  • Others

On the basis of animal, the Snakes segment is dominating the market and is likely to continue the trend during the forecast period. Factors such as the occurrence rate of snake bites in countries like India, Pakistan, Bangladesh, and other Asian and African countries are leading to a constant rise in demand for antivenom in these countries. Increasing awareness among people in rural areas about the seriousness of snakebites, unmet demand conditions of the antivenoms, improvisation of regulatory frameworks and approval procedures and increased government investments for developing high-quality antivenoms are contributing to the growth of snake segment in this market.

Regional Analysis:

North America is the dominating Global Antivenom Market accounting for a share of approximately 39.0% followed by Europe in 2016. Asia-Pacific is estimated to be the fastest-growing region with a CAGR of 8.59% during the forecast period of 2019 -2024.

Companies leading the Global Antivenom Market profiled in the report are:

  1. Instituto Bioclon, S.A. de C.V. (Mexico)
  2. Pfizer AG (Switzerland)
  3. CSL Limited (Australia)
  4. F. Hoffmann-La Roche Ltd. (Switzerland)
  5. Merck & Co., Inc. (U.S.)
  6. Rare Disease Therapeutics, Inc. (U.S.)
  7. Vins Bioproducts Limited (India)
  8. BTG Plc (U.K.)
  9. Incepta Vaccine Ltd. (Bangladesh)
  10. Bharat Serum

1. Introduction                        

            1.1 Market Definition            

            1.2 Study Deliverables                       

            1.3 Base Currency, Base Year and Forecast Periods              

            1.4 General Study Assumptions                     

2. Research Methodology

            2.1 Introduction                     

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research         

                        2.2.3 Econometric Modelling

                        2.2.4 Expert Validation          

            2.3 Analysis Design                

            2.4 Study Timeline                

3. Overview

            3.1 Executive Summary                     

            3.2 Key Inferences                 

            3.3 Epidemology                    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

            4.1 Market Drivers                 

            4.2 Market Restraints            

            4.3 Key Challenges                 

            4.4 Current Opportunities in the Market                  

5. Market Segmentation

            5.1 Type                     

                        5.1.1 Introduction      

                        5.1.2 Vaccines

                        5.1.3 Hyperimmune Sera       

                                    5.1.3.1 Homologous

                                    5.1.3.2 Heterologous

                        5.1.4  Y-o-Y Growth Analysis, By type            

                        5.1.5  Market Attractiveness Analysis, By Type         

                        5.1.6  Market Share Analysis, By Type           

            5.2 Animal                  

                        5.2.1 Introduction      

                        5.2.2 Snakes   

                        5.2.3 Scorpions           

                        5.2.4 Spiders  

                        5.2.5 Others   

                        5.2.6  Y-o-Y Growth Analysis, By Animal       

                        5.2.7  Market Attractiveness Analysis, By Animal     

                        5.2.8  Market Share Analysis, By Animal       

6. Geographical Analysis

            6.1 Introduction                     

                        6.1.1 Regional Trends

                        6.1.2 Impact Analysis 

                        6.1.3 Y-o-Y Growth Analysis  

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Type

                                    6.1.3.2 By Animal

                        6.1.4  Market Attractiveness Analysis

                                    6.1.4.1 By Geographical Area

                                    6.1.4.2 By Type

                                    6.1.4.2 By Animal

                        6.1.5  Market Share Analysis 

                                    6.1.5.1 By Geographical Area

                                    6.1.5.2 By Type

                                    6.1.5.2 By Animal

            6.2 North America                 

                        6.1.1 Introduction      

                        6.1.2 United States    

                        6.1.3 Canada  

            6.3 Europe                  

                        6.2.1 Introduction      

                        6.2.2 U.K         

                        6.2.3 Spain     

                        6.2.4 Germany

                        6.2.5 Italy       

                        6.2.6 France   

            6.4 Asia-Pacific                       

                        6.3.1 Introduction      

                        6.3.2 China     

                        6.3.3 India      

                        6.3.4 Japan     

                        6.3.5 Australia

                        6.3.6 South Korea      

            6.5 Latin America                   

                        6.4.1 Introduction      

                        6.4.2 Brazil     

                        6.4.3 Argentina          

                        6.4.4 Mexico  

                        6.4.5 Rest of Latin America   

            6.6 Middle East & Africa                    

                        6.5.1 Introduction      

                        6.5.2 Middle-East       

                        6.5.3 Africa    

7.Strategic Analysis                            

            7.1 PESTLE analysis                

                        7.1.1 Political 

                        7.1.2 Economic          

                        7.1.3 Social     

                        7.1.4 Technological    

                        7.1.5 Legal     

                        7.1.6 Environmental  

            7.2 Porter’s Five analysis                   

                        7.2.1 Bargaining Power of Suppliers  

                        7.2.2 Bargaining Power of Consumers          

                        7.2.3 Threat of New Entrants

                        7.2.4 Threat of Substitute Products and Services     

                        7.2.5 Competitive Rivalry within the Industry           

8.Market Leaders' Analysis                            

            8.1 Instituto Bioclon, S.A. de C.V.                  

                        8.1.1 Overview           

                        8.1.2 Product Analysis

                        8.1.3 Financial analysis          

                        8.1.4 Recent Developments   

                        8.1.5 SWOT analysis  

                        8.1.6 Analyst View     

            8.2 Pfizer AG              

            8.3 CSL Limited                      

            8.4 Roche                   

            8.5 Merck & Co                      

            8.6 Rare Disease Therapeutics, Inc.               

            8.7 Vins Bioproducts Limited             

            8.8 BTG Plc                 

            8.9 Incepta Vaccine Ltd                      

            8.10 Bharat Serim and Vaccines Limited (BSV)                     

9. Competitive Landscape                              

            9.1 Market share analysis                  

            9.2 Merger and Acquisition Analysis             

            9.3 Agreements, collaborations and Joint Ventures             

            9.4 New Product Launches                

10. Market Outlook and Investment Opportunities                           

Appendix                                

            a) List of Tables

            b) List of Figures

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Diabetes Care Devices Market By Region, From 2019-2024 ( USD Billion )
  2. Global Antivenom Market By Type, From 2019-2024 ( USD Billion )
  3. Global Vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Global Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  5. Global Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  6. Global Snakes Market By Region, From 2019-2024 ( USD Billion )
  7. Global Scorpions Market By Region, From 2019-2024 ( USD Billion )
  8. Global Spiders Market By Region, From 2019-2024 ( USD Billion )
  9. Global Others Market By Region, From 2019-2024 ( USD Billion )
  10. North America Antivenom Market By Type, From 2019-2024 ( USD Billion )
  11. North America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  12. North America Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  13. North America Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  14. North America Snakes Market By Region, From 2019-2024 ( USD Billion )
  15. North America Scorpions Market By Region, From 2019-2024 ( USD Billion )
  16. North America Spiders Market By Region, From 2019-2024 ( USD Billion )
  17. North America Others Market By Region, From 2019-2024 ( USD Billion )
  18. United States Antivenom Market By Type, From 2019-2024 ( USD Billion )
  19. United States Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  20. Canada Antivenom Market By Type, From 2019-2024 ( USD Billion )
  21. Canada Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  22. Europe Antivenom Market By Type, From 2019-2024 ( USD Billion )
  23. Europe Vaccines Market By Region, From 2019-2024 ( USD Billion )
  24. Europe Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  25. Europe Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  26. Europe Snakes Market By Region, From 2019-2024 ( USD Billion )
  27. Europe Scorpions Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Spiders Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  30. U.K. Antivenom Market By Type, From 2019-2024 ( USD Billion )
  31. U.K. Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  32. Germany Antivenom Market By Type, From 2019-2024 ( USD Billion )
  33. Germany Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  34. France Antivenom Market By Type, From 2019-2024 ( USD Billion )
  35. France Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  36. Italy Antivenom Market By Type, From 2019-2024 ( USD Billion )
  37. Italy Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  38. Spain Antivenom Market By Type, From 2019-2024 ( USD Billion )
  39. Spain Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  40. Asia-Pacific Antivenom Market By Type, From 2019-2024 ( USD Billion )
  41. Asia-Pacific Vaccines Market By Region, From 2019-2024 ( USD Billion )
  42. Asia-Pacific Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  43. Asia-Pacific Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  44. Asia-Pacific Snakes Market By Region, From 2019-2024 ( USD Billion )
  45. Asia-Pacific Scorpions Market By Region, From 2019-2024 ( USD Billion )
  46. Asia-Pacific Spiders Market By Region, From 2019-2024 ( USD Billion )
  47. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  48. Japan Antivenom Market By Type, From 2019-2024 ( USD Billion )
  49. Japan Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  50. China Antivenom Market By Type, From 2019-2024 ( USD Billion )
  51. China Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  52. India Antivenom Market By Type, From 2019-2024 ( USD Billion )
  53. India Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  54. Australia Antivenom Market By Type, From 2019-2024 ( USD Billion )
  55. Australia Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  56. South Korea Antivenom Market By Type, From 2019-2024 ( USD Billion )
  57. South Korea Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  58. Latin America Antivenom Market By Type, From 2019-2024 ( USD Billion )
  59. Latin America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  60. Latin America Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  61. Latin America Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  62. Latin America Snakes Market By Region, From 2019-2024 ( USD Billion )
  63. Latin America Scorpions Market By Region, From 2019-2024 ( USD Billion )
  64. Latin America Spiders Market By Region, From 2019-2024 ( USD Billion )
  65. Latin America Others Market By Region, From 2019-2024 ( USD Billion )
  66. Brazil Antivenom Market By Type, From 2019-2024 ( USD Billion )
  67. Brazil Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  68. Argentina Antivenom Market By Type, From 2019-2024 ( USD Billion )
  69. Argentina Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  70. Mexico Antivenom Market By Type, From 2019-2024 ( USD Billion )
  71. Mexico Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  72. Middle East & Africa Antivenom Market By Type, From 2019-2024 ( USD Billion )
  73. Middle East & Africa Vaccines Market By Region, From 2019-2024 ( USD Billion )
  74. Middle East & Africa Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  75. Middle East & Africa Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  76. Middle East & Africa Snakes Market By Region, From 2019-2024 ( USD Billion )
  77. Middle East & Africa Scorpions Market By Region, From 2019-2024 ( USD Billion )
  78. Middle East & Africa Spiders Market By Region, From 2019-2024 ( USD Billion )
  79. Middle East & Africa Others Market By Region, From 2019-2024 ( USD Billion )
  80. Middle East Antivenom Market By Type, From 2019-2024 ( USD Billion )
  81. Middle East Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  82. Africa Antivenom Market By Type, From 2019-2024 ( USD Billion )
  83. Africa Antivenom Market By Animal, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample